Patents Assigned to Sirn Therapeutics, Inc.
  • RNA interference mediated target discovery and target validation using short interfering nucleic acid (siNA)
    Publication number: 20050142578
    Abstract: The present invention concerns methods and reagents useful in target discovery. Specifically, the invention relates to small nucleic acid molecules capable of mediating RNA interference (RNAi), such as short interfering nucleic acid (siNA) short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules and methods of target discovery using siRNA.
    Type: Application
    Filed: August 19, 2004
    Publication date: June 30, 2005
    Applicant: Sirn Therapeutics, Inc.
    Inventors: Nassim Usman, Barry Polisky, James Thompson, Leonid Beigelman